Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/33234
Title: hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes
Authors: Hancox, J. C.
Melgari, D.
Dempsey, C. E.
Brack, Kieran E.
Mitcheson, John
Ng, G. André
First Published: 13-Jul-2015
Publisher: SAGE Publications
Citation: Therapeutic Advances in Drug Safety, 2015, 6 (4), pp. 177-179
DOI Link: 10.1177/2042098615595546
ISSN: 2042-0986
Links: http://taw.sagepub.com/content/6/4/177
http://hdl.handle.net/2381/33234
Version: Post-print
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © the authors, 2015. Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav
Description: Deposited with reference to the publisher's Green Open Access policy, available at https://uk.sagepub.com/en-gb/eur/the-green-route-%E2%80%93-open-access-archiving-policy
Appears in Collections:Published Articles, Dept. of Cell Physiology and Pharmacology

Files in This Item:
File Description SizeFormat 
Ivabradine letter for TADS Revision V1_31MAY15DMJCHJM_revised.docPost-review (final submitted)85 kBMicrosoft WordView/Open
Ivabradine letter for TADS Revision V1_31MAY15DMJCHJM_revised.pdfPost-review (final submitted)243.16 kBAdobe PDFView/Open


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.